ACTEMRA® (tocilizumab) Treatment Information for Healthcare Professionals

Meta Data Analysis

Description	HCP info about ACTEMRA® (tocilizumab) treatment for SJIA, PJIA, GCA, SSc-ILD, COVID-19, & RA patients. See Full Safety and Boxed Warnings for more information.
h1 tags	Important Safety Information
h2 tags	INDICATIONS RISK OF SERIOUS INFECTIONS: CONTRAINDICATION WARNINGS AND PRECAUTIONS Gastrointestinal Perforations Hepatotoxicity Laboratory Parameters Immunosuppression Hypersensitivity Reactions Demyelinating Disorders Active Hepatic Disease and Hepatic Impairment Vaccinations ADVERSE REACTIONS RHEUMATOID ARTHRITIS (RA) GIANT CELL ARTERITIS (GCA) Infections POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS (PJIA) Infections Infusion Reactions SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA) Infections Macrophage Activation Syndrome Infusion Reactions Anaphylaxis CORONAVIRUS DISEASE 2019 (COVID-19) Laboratory Abnormalities DRUG INTERACTIONS USE IN PREGNANCY
Site Speed	0.7245020866394

Alexa Rank:	0
Site's Traffic

Host	Type	Class	TTL	Target
actemrahcp.com	HINFO	IN	3600